Smoking and disease progression in multiple sclerosis

Archives of Neurology

Volumn 66, Issue 7, 2009, Pages 858-864

  Healy, Brian C ^a,c   Ali, Eman N ^a   Guttmann, Charles R G ^a   Chitnis, Tanuja ^a   Glanz, Bonnie I ^a   Buckle, Guy ^a   Houtchens, Maria ^a   Stazzone, Lynn ^a   Moodie, Jennifer ^a   Berger, Annika M ^a   Duan, Yang ^a   Bakshi, Rohit ^a   Khoury, Samia ^a   Weiner, Howard ^a   Ascherio, Alberto ^b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER;

ADULT; ARTICLE; BRAIN; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH SURVEY; HUMAN; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; REMISSION; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; AGED; BRAIN INFARCTION; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 67650466194     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.122     Document Type: Article

References (35)

1. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis, part II: noninfectious factors. Ann Neurol. 2007;61(6):504-513.
2. Di Pauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler. 2008;14(8):1026-1030.
3. Hernán MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain. 2005;128(pt 6):1461-1465.
4. Koch M, van Harten A, Uyttenboogaart M, De Keyser J. Cigarette smoking and progression in multiple sclerosis. Neurology. 2007;69(15):1515-1520.
5. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001;50(1):121-127.
6. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol. 2005;58(6):840-846.
7. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology. 2005;64(7):1144-1151.
8. Warfield SK, Kaus M, Jolesz FA, Kikinis R. Adaptive, template moderated, spatially varying statistical classification. Med Image Anal. 2000;4(1):43-55.
9. Wei X, Warfield SK, Zou KH, et al. Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy. J Magn Reson Imaging. 2002;15(2):203-209.
10. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System. 2nd ed. New York, NY: John Wiley & Sons Inc; 2001.
11. R Development Core Team. R: a Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2007.
12. Franklin CR, Brickner RM. Vasospasm associated with multiple sclerosis. Arch Neurol Psychiatry. 1947;58:125-162.
13. Spillane JD. The effect of nicotine on spinocerebellar ataxia. Br Med J. 1955;2(4952):1345-1351.
14. MB. BS. Smoking and multiple sclerosis [letter]. BMJ. 1964;1:773.
15. Perkin GD, Bowden P, Rose FC. Smoking and optic neuritis. Postgrad Med J. 1975;51(596):382-385.
16. Perkin GD, Rose FC. Uhthoff's syndrome. Br J Ophthalmol. 1976;60(1):60-63.
17. Emre M, de Decker C. Effects of cigarette smoking on motor functions in patients with multiple sclerosis. Arch Neurol. 1992;49(12):1243-1247.
18. Emre M, de Decker C. Nicotine and CNS. Neurology. 1987;37(12):1887-1888.
19. Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology. 2003;61(8):1122-1124.
20. Hernán MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol. 2001;154(1):69-74.
21. Mikaeloff Y, Caridade G, Tardieu M, Suissa S; KIDSEP Study Group. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain. 2007;130(pt 10):2589-2595.
22. Sundström P, Nyström L, Hallmans G. Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol. 2008;15(6):579-583.
23. Smith AD, Duckett S, Waters AH. Neuropathological changes in chronic cyanide intoxication. Nature. 1963;200:179-181.
24. Bass NH. Pathogenesis of myelin lesions in experimental cyanide encephalopathy: a microchemical study. Neurology. 1968;18(2):167-177.
25. Lessell S. Experimental cyanide optic neuropathy. Arch Ophthalmol. 1971;86(2):194-204.
26. Chen JL, Wei L, Bereczki D, et al. Nicotine raises the influx of permeable solutes across the rat blood-brain barrier with little or no capillary recruitment. J Cereb Blood Flow Metab. 1995;15(4):687-698.
27. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998;83(1-2):148-156.
28. Francus T, Klein RF, Staiano-Coico L, Becker CG, Siskind GW. Effects of tobacco glycoprotein (TGP) on the immune system, II: TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells [published correction appears in J Immunol. 1988;140(12):4413.]. J Immunol. 1988;140(6):1823-1829.
29. Rejdak K, Eikelenboom MJ, Petzold A, et al. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology. 2004;63(8):1439-1445.
30. Gallinat J, Meisenzahl E, Jacobsen LK, et al. Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci. 2006;24(6):1744-1750.
31. Fukuda H, Kitani M. Cigarette smoking is correlated with the periventricular hyperintensity grade of brain magnetic resonance imaging. Stroke. 1996;27(4):645-649.
32. Cuba Neuropathy Field Investigation Team. Epidemic optic neuropathy in Cuba: clinical characterization and risk factors. N Engl J Med. 1995;333(18):1176-1182.
33. Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus. 2006;15(11):737-745.
34. Graham NM. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev. 1990;12:149-178.
35. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet. 1985;1(8441):1313-1315.